Case-control study of thromboembolic events associated with IV immunoglobulin

Journal of Neurology

Volumn 256, Issue 3, 2009, Pages 339-342

  Caress, J B ^a   Hobson Webb, L ^b   Passmore, L V ^a   Finkbiner, A P ^a   Cartwright, M S ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cerebrovascular disorders; Immunoglobulins; Myocardial infarction; Stroke; Thrombosis

Indexed keywords

IMMUNOGLOBULIN;

ACCURACY; ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DRUG DOSE INCREASE; FEMALE; HEART INFARCTION; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INCIDENCE; INFLAMMATORY DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PRESCRIPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; STROKE; THROMBOEMBOLISM;

ADULT; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; ODDS RATIO; RISK FACTORS; STROKE; THROMBOEMBOLISM;

EID: 67349259156     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-009-0969-0     Document Type: Article

References (16)

1. Brannagan 1996 Neurology 47 674
2. Caress 2003 Neurology 60 1822
3. Cooperative Group for the Study of Immunoglobulin in Chronic Lymphocytic Leukemia (1988) Intravenous immunoglobulin for the prevention of infection in chronic lymphocytic leukemia. N Engl J Med 319:902-907
4. Dalakas 1994 Neurology 44 223
5. Fazekas 1997 Lancet 349 589
6. Hommes 2004 Lancet 364 1149
7. Lapointe 2004 Brain 127 2649
8. Marie 2006 Br J Dermatol 155 714
9. Paran 2005 Blood Coagul Fibrinolysis 16 313
10. Sherer 2001 Pharmacology 62 133
11. Stangel 2003 J Neurol 250 818
12. Steg 1994 Neurology 44 1180
13. Voltz 1996 Neurology 46 250
14. Vucic 2004 Eur Neurol 52 141
15. Wittstock 2003 Eur Neurol 50 172
16. Wolberg 2000 Am J Hematol 65 30